Compare Stocks

→ You’re invited: Biggest crypto event of 2024 (From InvestorPlace) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CATH Global X S&P 500 Catholic Values ETF	$60.50 -0.1%	$61.98	$49.45 ▼ $63.77	$797.39M	1.01	31,387 shs	16,704 shs
INDY iShares India 50 ETF	$49.44 -0.1%	$50.29	$41.42 ▼ $51.53	$850.37M	0.7	86,130 shs	99,763 shs
NXTG First Trust Indxx NextG ETF	$74.34 -0.1%	$77.91	$64.46 ▼ $81.22	$364.27M	0.89	10,044 shs	29,890 shs
PPH VanEck Pharmaceutical ETF	$84.87 -0.4%	$88.82	$74.05 ▼ $91.16	$512.62M	0.72	125,060 shs	98,220 shs

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CATH Global X S&P 500 Catholic Values ETF	-0.13%	-3.69%	-3.51%	+3.12%	+19.24%
INDY iShares India 50 ETF	-0.12%	-2.68%	-0.22%	+0.10%	+18.93%
NXTG First Trust Indxx NextG ETF	-0.11%	-4.75%	-4.84%	-2.95%	+8.94%
PPH VanEck Pharmaceutical ETF	-0.38%	-2.22%	-5.26%	+0.58%	+7.83%

New crypto project uncovers 2,050% in 65 days (Ad)

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CATH Global X S&P 500 Catholic Values ETF	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
INDY iShares India 50 ETF	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
NXTG First Trust Indxx NextG ETF	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PPH VanEck Pharmaceutical ETF	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating	Consensus Price Target	% Upside from Current Price
CATH Global X S&P 500 Catholic Values ETF	N/A	$68.04	12.46% Upside
INDY iShares India 50 ETF	N/A	N/A	N/A
NXTG First Trust Indxx NextG ETF	N/A	$82.53	11.01% Upside
PPH VanEck Pharmaceutical ETF	N/A	$99.19	16.88% Upside

Current Analyst Ratings

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CATH Global X S&P 500 Catholic Values ETF	N/A	N/A	N/A	N/A	N/A	N/A
INDY iShares India 50 ETF	N/A	N/A	N/A	N/A	N/A	N/A
NXTG First Trust Indxx NextG ETF	N/A	N/A	N/A	N/A	N/A	N/A
PPH VanEck Pharmaceutical ETF	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CATH Global X S&P 500 Catholic Values ETF	N/A	N/A	16.67	∞	N/A	N/A	N/A	N/A	N/A
INDY iShares India 50 ETF	N/A	N/A	22.30	∞	N/A	N/A	N/A	N/A	N/A
NXTG First Trust Indxx NextG ETF	N/A	N/A	18.09	∞	N/A	N/A	N/A	N/A	N/A
PPH VanEck Pharmaceutical ETF	N/A	N/A	16.59	∞	N/A	N/A	N/A	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CATH Global X S&P 500 Catholic Values ETF	$0.67	1.11%	N/A	N/A	N/A
INDY iShares India 50 ETF	$0.19	0.38%	N/A	N/A	N/A
NXTG First Trust Indxx NextG ETF	$1.64	2.21%	N/A	N/A	N/A
PPH VanEck Pharmaceutical ETF	$1.56	1.84%	N/A	N/A	N/A

Latest INDY, NXTG, CATH, and PPH Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
3/28/2024	PPH VanEck Pharmaceutical ETF		$0.5328		4/1/2024	4/2/2024	4/5/2024
3/20/2024	NXTG First Trust Indxx NextG ETF	Quarterly	$0.0440		3/21/2024	3/22/2024	3/28/2024

(Data available from 1/1/2013 forward)

Ownership

Institutional Ownership

Company	Institutional Ownership
CATH Global X S&P 500 Catholic Values ETF	N/A
INDY iShares India 50 ETF	N/A
NXTG First Trust Indxx NextG ETF	N/A
PPH VanEck Pharmaceutical ETF	N/A

Insider Ownership

Company	Insider Ownership
CATH Global X S&P 500 Catholic Values ETF	N/A
INDY iShares India 50 ETF	N/A
NXTG First Trust Indxx NextG ETF	N/A
PPH VanEck Pharmaceutical ETF	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
CATH Global X S&P 500 Catholic Values ETF	147,000	13.18 million	N/A	Optionable
INDY iShares India 50 ETF	147,000	17.20 million	N/A	Optionable
NXTG First Trust Indxx NextG ETF	147,000	4.90 million	N/A	Optionable
PPH VanEck Pharmaceutical ETF	147,000	6.04 million	N/A	Optionable

INDY, NXTG, CATH, and PPH Headlines

Source	Headline
	Canada’s updated guidance on ESG-related investment fund disclosure theglobeandmail.com - April 18 at 10:38 AM
	JNJ Beats Q1 Earnings Estimates, Misses on Sales: ETFs in Focus zacks.com - April 17 at 11:00 AM
	VanEck Pharmaceutical ETF declares quarterly distribution of $0.5328 msn.com - April 3 at 8:35 AM
	VanEck Vectors Pharmaceutical ETF declares quarterly distribution of $0.5328 msn.com - April 1 at 2:26 PM
	Should You Invest in the VanEck Pharmaceutical ETF (PPH)? zacks.com - March 8 at 7:21 AM
	The Top 3 ETFs to Buy in March 2024 investorplace.com - March 7 at 1:43 PM
	11 'Granolas' Stocks Outperform Magnificent 7 With Lower Volatility, Higher Yields markets.businessinsider.com - February 28 at 3:40 PM
	Navigate to Success With These 4 Pharma Stocks to Buy stocknews.com - February 28 at 1:01 PM
	The 3 Hottest Healthcare ETFs to Buy in 2024 investorplace.com - February 26 at 2:12 PM
	PPH VanEck Pharmaceutical ETF seekingalpha.com - February 21 at 8:39 PM
	Healthcare dealmakers see increased M&A, valuations in 2024: KPMG msn.com - February 20 at 7:16 AM
	Pharma ETF (PPH) Hit a 52-Week High zacks.com - February 19 at 9:50 AM
	Big Pharma earnings season in spotlight amid positive sentiment msn.com - January 28 at 1:06 PM
	5 ETF Zones Scaling New Highs at the Start of 2024 finance.yahoo.com - January 8 at 1:13 PM
	Pfizer in 2024: What to expect? msn.com - December 29 at 1:39 PM
	Gilead in 2024: What to expect? msn.com - December 28 at 1:41 PM
	ETFs to buy and sell as the GLP-1 craze booms cnbc.com - December 6 at 9:53 AM
	10 Best Performing Healthcare ETFs in 2023 uk.finance.yahoo.com - November 14 at 4:43 PM
	Pharma to Farmers: My 3 Favorite “Essential” ETFs To Consider Adding To Your Portfolio msn.com - November 6 at 1:27 PM
	PPH ETF Stock Price History investing.com - November 1 at 5:10 PM
	PPH: GLP-1 Companies And Large-Cap Value Pharma Make For A Compelling Portfolio msn.com - October 29 at 7:35 AM
	3 Resilient Pharma Stocks to Buy This Week stocknews.com - October 26 at 9:05 PM
	Ozempic craze drives big flows into pharmaceutical, Danish funds msn.com - October 25 at 12:42 PM
	Eli Lilly, Novo among notable decliners in pharma weakness seekingalpha.com - October 19 at 11:42 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Global X S&P 500 Catholic Values ETF

NASDAQ:CATH

The Global X S&P 500 Catholic Values ETF (CATH) is an exchange-traded fund that is based on the S&P 500 Catholic Values index. The fund tracks an index of US large-cap stocks selected from the S&P 500. The cap-weighted index omits companies from certain industries at odds with Catholic values. CATH was launched on Apr 18, 2016 and is managed by Global X.

iShares India 50 ETF

NASDAQ:INDY

iShares India 50 ETF, formerly iShares S&P India Nifty 50 Index Fund, seeks investment results that correspond generally to the price and yield performance of the S&P CNX Nifty Index (the Index). The Index measures the equity performance of the top 50 companies by market capitalization that trade in the Indian market. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund's investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.

First Trust Indxx NextG ETF

NASDAQ:NXTG

The First Trust IndXX NextG ETF (NXTG) is an exchange-traded fund that is based on the Indxx 5G & NextG Thematic index. The fund tracks a tiered-weighted index of global equities related to next generation digital cellular technologies. NXTG was launched on Feb 17, 2011 and is managed by First Trust.

VanEck Pharmaceutical ETF

NASDAQ:PPH

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial